Langerhans cell histiocytosis (LCH): treatment
Evidence-based neurology checklist on langerhans cell histiocytosis (lch): treatment: Treatment of skin lesions Topical steroids Topical tacrolimus Topical nitrogen mustard Topical PUVA Oral methotrexate Oral hydroxyurea Thalidomide Treatment of single organ lung lesions Treatment of multifocal…
Treatment of skin lesions
- Topical steroids
- Topical tacrolimus
- Topical nitrogen mustard
- Topical PUVA
- Oral methotrexate
- Oral hydroxyurea
- Thalidomide
Treatment of single organ lung lesions
Treatment of multifocal bone lesions
Treatment of multifocal skin lesions
Treatment of multi-organ disease
Treatment of neurodegenerative symptoms
Other treatments
Investigational treatments
Treatments to avoid
Synonym
References
- Satter EK, High WA. Langerhans cell histiocytosis: a review of the current recommendations of the Histiocyte Society. Pediatr Dermatol 2008; 25:291-295.
- Leung AKC, Lam JM, Leong KF. Childhood Langerhans cell histiocytosis: a disease with many faces. World J Pediatr 2019; 15:536-545.
- Girschikofsky M, Arico M, Castillo D, et al. Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net.Orphanet J Rare Dis 2013; 8:72.
- Goyal G, Tazi A, Go RS, et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood 2022; 139:2601-2621.
- Donadieu J, Chalard F, Jeziorski E. Medical management of Langerhans cell histiocytosis from diagnosis to treatment. Expert Opin Pharmacother 2012; 13:1309-1322.
